Drugs / Cimifuga Racemosa
last change May 2019 re-read 2 minutes ago

Cimifuga Racemosa

Developed for
polycystic ovary syndrome
Investigated by
Federal University of Minas Gerais

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT03786809 Jun 2016 → Apr 2019 Federal University of Minas Gerais Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02352597 Comparator Jan 2013 → Jan 2015 polycystic ovary syndrome Cairo University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Cimifuga Racemosa “received phytoestrogen (20mg of cimifuga racemosa from day 1- 12)” NCT02352597
1

NCT03786809